Search

Meeting Coverage:

American Academy of Ophthalmology

AAO: 2015

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Show Description +

Jonathan Prenner, MD, interviews David M. Brown, MD, about a DAVE trial in which researchers used targeted PRP in combination with anti-VEGF therapy to improve outcomes in patients with DME. Researchers hypothesized that by targeting VEGF-producing tissue, one could reduce treatment burden. Dr. Brown compares visual acuity outcomes in patients with anti-VEGF therapy and PRP with patients receiving anti-VEGF monotherapy.

Posted: 11/17/2015

Keywords:

Anti-VEGF

•

Retina

•

Retina Subspecialty Day

Up Next

Optimum Timing: Pars Plana Vitrectomy

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD

Potential Treatments for AMD

Potential Treatments for AMD

Thomas Ciulla, MD

YAG Rates: Femto vs Phaco

YAG Rates: Femto vs Phaco

Dan B. Tran, MD, Sonia Manning, MD

An Important Diagnosis: Conjunctival Melanoma

An Important Diagnosis: Conjunctival Melanoma

Carol L. Shields, MD, Mark Kontos, MD

Cross-Linking for Keratoconus

Cross-Linking for Keratoconus

Parag Majmudar MD, Terry Kim, MD

Intraoperative OCT: Impact on Macular Surgery

Intraoperative OCT: Impact on Macular Surgery

Justis Ehlers, MD

A Novel IOL Implant

A Novel IOL Implant

Louis D. Nichamin MD, Mark Kontos, MD

Placing iStents: Potential Challenges

Placing iStents: Potential Challenges

Steven Sarkisian, MD, Steven Vold, MD

Advances With 24-Hour IOP Monitoring

Advances With 24-Hour IOP Monitoring

Kaweh Mansouri, MD, Ranna Jaraha

New Technique for Lens Rescue

New Technique for Lens Rescue

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

$Corneal Refractive Surgery: Impact on Cataract Extraction$

Corneal Refractive Surgery: Impact on Cataract Extraction

Dan B. Tran, MD, Sonia Manning, MD

Role-Playing: Difficult Scenarios

Role-Playing: Difficult Scenarios

Christopher Starr, MD, Neda Shamie, MD

Phakic IOLs: What's Now, What's Next

Phakic IOLs: What's Now, What's Next

Allon Barsam, MB, BS, MA, FRCOphth, Ranna Jaraha

Predictive Modeling for Lens Position

Predictive Modeling for Lens Position

John Davidson, MD, Joseph J.K. Ma, MD, FRCSC

PVR Prevention: Identifying High-Risk Features

PVR Prevention: Identifying High-Risk Features

Jonathan L. Prenner, MD, Richard S. Kaiser, MD

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Back to All Videos

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Jonathan Prenner, MD, interviews David M. Brown, MD, about a DAVE trial in which researchers used targeted PRP in combination with anti-VEGF therapy to improve outcomes in patients with DME. Researchers hypothesized that by targeting VEGF-producing tissue, one could reduce treatment burden. Dr. Brown compares visual acuity outcomes in patients with anti-VEGF therapy and PRP with patients receiving anti-VEGF monotherapy.

Posted: 11/17/2015

Keywords:

Anti-VEGF

•

Retina

•

Retina Subspecialty Day

Please log in to leave a comment.

More From AAO: 2015 Coverage

Protocol S

Protocol S

Jeffrey Gross, MD, Scott Krzywonos

Optimum Timing: Pars Plana Vitrectomy

Optimum Timing: Pars Plana Vitrectomy

Caroline Baumal, MD , Richard Kaiser, MD

Potential Treatments for AMD

Potential Treatments for AMD

Thomas Ciulla, MD

YAG Rates: Femto vs Phaco

YAG Rates: Femto vs Phaco

Dan B. Tran, MD, Sonia Manning, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2015.